Sensing the Simmering Inflammation: Clues for Diagnosis of Underlying Rheumatic Disorder

Chandrika S Bhat1, Athimalaipet V Ramanan2, Narendra Kumar Bagri3

  • 1Pediatric Rheumatology Services, Rainbow Children's Hospital, Bangalore, Karnataka, India.

Indian Pediatrics
|September 13, 2024
PubMed

Insights

Diagnosing pediatric rheumatic diseases requires careful pattern recognition of clinical and laboratory features to avoid delays. Early diagnosis is crucial for preventing long-term joint damage and organ involvement, leading to better patient outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Diagnostics

Background:

  • Pediatric rheumatic diseases present diagnostic challenges due to overlapping symptoms with infections and malignancies.
  • Delayed diagnosis can result in severe joint disabilities and life-threatening organ damage.

Purpose of the Study:

  • To highlight key clinical and laboratory features for early diagnosis of pediatric rheumatic disorders.
  • To assist primary care pediatricians in identifying these conditions promptly.

Main Methods:

  • Review of characteristic clinical presentations.
  • Emphasis on detailed patient history and physical examination.
  • Integration of accessible laboratory investigations.

Main Results:

  • Pattern recognition of specific signs and symptoms aids diagnosis.
  • Laboratory tests provide crucial guidance for identifying rheumatic conditions.
  • Early identification facilitates timely intervention.

Conclusions:

  • Prompt diagnosis of pediatric rheumatic diseases is essential for mitigating long-term morbidity.
  • A systematic approach combining clinical evaluation and laboratory data improves diagnostic accuracy.
  • Effective therapeutic options are available for favorable outcomes when initiated early.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
324
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
396
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
410
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
201
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120